The first amylin agonist (pramlintide) was approved only for diabetes, requiring multiple daily injections and producing modest weight loss
This review summarized the experimental shreds of evidence from studies using GLP-1R agonists to describe the neural and endocrine integration of stress responses and feeding behavior
We aim to achieve a meaningful shift through continuous awareness, education and coordinated efforts across the healthcare ecosystem, Shrotriya said
Tirzepatide is available in escalating doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg) to allow gradual titration, minimizing gastrointestinal side effects while optimizing therapeutic response
This introduces variability in pharmacodynamics, as GLP-1RA penetration into specific brain regions may differ based on sex, compound properties, and age ( This raises important questions for ongoing trials such as EVOKE, which may uncover sex-specific differences and justify subsequent investigations of GLP-1 analogues in female populations
